The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area.
 
Salvatore Alfieri
No Relationships to Disclose
 
Carlo Resteghini
No Relationships to Disclose
 
Laura Pala
No Relationships to Disclose
 
Sara Marceglia
No Relationships to Disclose
 
Nicola Alessandro Iacovelli
No Relationships to Disclose
 
Ester Orlandi
No Relationships to Disclose
 
Annunziata Gloghini
No Relationships to Disclose
 
Giovanni Pietro Gesu
No Relationships to Disclose
 
Diana Fanti
No Relationships to Disclose
 
Sara Racca
No Relationships to Disclose
 
Roee Dvir
No Relationships to Disclose
 
Daniele Morelli
No Relationships to Disclose
 
Francesca Taverna
No Relationships to Disclose
 
Pasquale Quattrone
No Relationships to Disclose
 
Cristiana Bergamini
No Relationships to Disclose
 
Roberta Granata
No Relationships to Disclose
 
Maria Chiara Cau
No Relationships to Disclose
 
Laura D. Locati
No Relationships to Disclose
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Debiopharm Group; Eisai; GlaxoSmithKline; Merck Serono; MSD; Novartis; SOBI; VentiRx
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Bayer; Celgene; Debiopharm Group; Merck Serono; MSD; SOBI
 
Paolo Bossi
No Relationships to Disclose